BioNano Genomics has named Garth Monroe as its new chief financial officer.

Prior to joining BioNano, Monroe served as CFO for Epocal, a multi-national, venture-backed medical device company. He previously served as station manager for JetBlue Airways and a financial analyst at United Technologies.

Monroe is a certified public accountant and holds a BSc in business administration from the University of Connecticut and an MBA from the University of Virginia’s Darden School of Business.